Meta-Analysis
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Jun 27, 2022; 14(6): 594-610
Published online Jun 27, 2022. doi: 10.4240/wjgs.v14.i6.594
Table 1 Characteristics of the included studies
Ref.
Study type
Country
Period
Number (URY/BB)
Gender (M/F)
Age (URY/BB)
BMI
ASA (I/II/III)
Tumor stage (I/II/III/IV)
Differentiation (H/M/L)
Matched factors1
NOS score
Chen[30], 2018RCTChina2016.5-2017.9URY 30, BB 3017/13, 16/1455.00 ± 5.40, 53.50 ± 7.5622.89 ± 4.23, 21.38 ± 2.02NR3/10/17/0, 4/12/14/05/15/10, 4/14/121, 2, 3, 4, 7, 8, 12NA
Gao and Xiang[29], 2018RetroChina2014.1-2017.1URY 26, BB 3417/9, 21/1360.61 ± 11.14, 59.72 ± 10.7921.58 ± 1.86, 21.35 ± 1.93NR0/5/14/7, 0/7/18/98/7/11, 10/11/131, 2, 3, 5, 6, 9, 10, 11, 12, 138
Li et al[32], 2017RetroChina2010.1-2016.1URY 30, BB 3321/9, 21/1252.81 ± 5.39, 52.09 ± 6.4721.66 ± 2.54, 21.81 ± 2.62NRNG8/11/11, 9/12/121, 2, 3, 5, 6, 9, 127
Ren et al[31], 2020RCTChina2015.6-2016.12URY 44, BB 4430/14, 28/1659.61 ± 11.14, 59.72 ± 10.7921.51 ± 1.86, 21.38 ± 1.93NR0/8/25/11, 0/9/23/1214/13/17, 13/14/171, 3, 5, 6, 9, 10, 11, 13NA
Wang et al[36], 2018RetroChina2015.3-2017.6URY 81, BB 5852/29, 46/1256 (30-79), 56.5 (24-77)NRNR41/20/17/0, 28/13/16/0NR1, 3, 4, 5, 6, 98
Wang et al[34], 2021RCTChina2017.1-2018.5URY 62, BB 6244/18, 44/1854.84 ± 8.31; 54.69 ± 10.0722.43 ± 3.07, 22.46 ± 3.1727/28/7, 16/41/5NGNR1, 2, 3, 4, 5, 7, 8, 9, 10, 11, 12NA
Wu et al[33], 2021RetroChina2016.1-2019.4URY 45, BB 5027/18, 31/1959.1 ± 6.2, 59.1 ± 6.323.3 ± 3.0, 23.2 ± 2.9NR45/0/0/0, 50/0/0/07/15/23, 8/19/231, 2, 3, 4, 5, 9, 10, 11, 12, 136
Zhou et al[35], 2018RetroChina2010.6-2015.4URY 36, BB 3922/14, 24/1561 ± 5, 61 ± 823 ± 3, 22 ± 421/15/0, 23/16/036/0/0/0, 39/0/0/011/16/9, 10/19/102, 3, 4, 5, 6, 9, 10, 138